Actarit Market In Global
Actarit is an orally active immunomodulator that reduces symptoms in animal models and clinical t ... Read More
Pranlukast is an orally bioavailable cysteinyl leukotriene 1 (CysLT1) receptor antagonist.
This report contains market size and forecasts of Pranlukast in global, including the following market information:
Global Pranlukast Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pranlukast Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pranlukast companies in 2021 (%)
The global Pranlukast market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pranlukast include Merck, Cayman Chemical, TCI, Selleck Chemicals, Bio-Techne, LifeSpan BioSciences, AbMole, Abcam and Spectrum Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pranlukast manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pranlukast Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pranlukast Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Pranlukast Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pranlukast Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Pranlukast Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pranlukast Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pranlukast revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pranlukast revenues share in global market, 2021 (%)
Key companies Pranlukast sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pranlukast sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Cayman Chemical
TCI
Selleck Chemicals
Bio-Techne
LifeSpan BioSciences
AbMole
Abcam
Spectrum Chemical
LGC
Santa Cruz Biotechnology
Focus Biomolecules
Biosynth Carbosynth
BOC Sciences
Ark Pharm
Aladdin
Actarit is an orally active immunomodulator that reduces symptoms in animal models and clinical t ... Read More
Pitavastatin CalciumĀ is a competitive inhibitor of HMG-CoA reductase.
This report ... Read More
Imiquimod is a caspase 3 activator which acts as an immunomodulator and displays antiviral and an ... Read More
Etofenamate is a non-steroidal anti-inflammatory drug and diethylene glycol ester form of flufena ... Read More